Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A consultation with our licensed medical practitioner is required to determine if GLP-1 therapy is right for you
When claims are drawn from these sources, they are attributed to "Omzo's published materials" or "per Omzo's Terms." FDA.gov primary sources: The FDA's public page on unapproved GLP-1 drugs, the April 30, 2026 FDA press release on the 503B Bulks List proposal, and the Federal Register notice 91 Fed
Clinical support matters because dosing decisions should be made with medical guidance, especially when dealing with muscle pain , anxiety , or other concerning symptoms
In the eating behavior sub-study, 31 of 36 retatrutide-treated participants reported noticeable changes in eating behaviors within the first 8 weeks
Nasal delivery of GLP-1 RA has the potential to suppress appetite ignited in the olfactory bulb, which is distinct from the regular systemic administration mechanism
I know there are thousands of people out there who have never gotten insurance approval and have been paying out of pocket all along
